InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 40.93
-0.91 (-2.17%)
Last updated: Aug 15, 2025
InventisBio Market Cap
InventisBio has a market cap or net worth of 23.50 billion as of August 15, 2025. Its market cap has increased by 445.43% in one year.
Market Cap
23.50B
Enterprise Value
21.89B
Revenue
168.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.93
Market Cap Chart
Since July 25, 2022, InventisBio's market cap has increased from 8.79B to 23.50B, an increase of 167.27%. That is a compound annual growth rate of 37.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 23.50B | 206.33% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
| Jul 25, 2022 | 8.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 417.74B |
| WuXi AppTec | 286.10B |
| Shenzhen Mindray Bio-Medical Electronics | 286.01B |
| Sichuan Biokin Pharmaceutical | 126.19B |
| Aier Eye Hospital Group | 121.03B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.00B |
| Shanghai United Imaging Healthcare | 107.46B |
| Yunnan Baiyao Group Co.,Ltd | 99.92B |